Follow Us Here:

Cancer Knowledge Network

Cancer Knowledge Network and Current Oncology are proudly published by Multimed Inc.
0
Menu
The Oncologist, the Patient and CKN — Sharing Knowledge

Mike Neal, One Fertility, Comments on: Fertility risk discussion in young patients diagnosed with colorectal cancer

Commentary by Mike Neal

The retrospective chart review of 59 cancer patients by Kumar and colleagues found that the discussion about fertility preservation for patients diagnosed with colorectal cancer was occurring infrequently for newly diagnosed patients.  This highlights an important void in the general discussion about the cancer treatment side effects and more specifically how it relates to the individual’s fertility.

Quality of life issues are very important in this cohort of patients.  While the first priority is to save the life of the patient it is well known that the hope of being able to have their own biological children in the future is a positive influence for cancer patients. Moreover, it has been acknowledged that truly informed consent about cancer treatment must include the potential impact on the individual’s future fertility.  Advances in cancer treatment have been parallel to improvements in the field of assisted conception.  As a result, these two disciplines are intersecting to be able to provide complimentary treatment and options related to fertility preservation.  Therefore, it is helpful for oncologists to team up with fertility specialists to increase the awareness about fertility preservation opportunities for cancer patients.

Read the article in the Current Oncology Journal by A. Kumar , BESc MD, A. Merali, BPharm MD, G.R. Pond , PhD, K. Zbuk, MD

Read Sarah Isenberg’s Personal Story here.

 


Michael Neal, BSc. (Hons), MSc, PhD(c)

Scientific Director, ONE Fertility, Burlington, Ontario, Canada (www.onefertility.com)

Michael Neal completed his Masters Degree in Biomedical Sciences at the University of Guelph, focusing on the reproductive consequences of chromosome abnormalities. He is in the final stages of completing a PhD in the Medical Sciences program in the Reproductive Biology Division at McMaster University, Hamilton, Canada.

Mike’s experience in clinical Assisted Reproductive Technologies and his keen research interests have gained him an international reputation for innovation and excellence. He has numerous peer-reviewed publications and is a frequent reviewer for many major scientific journals related to reproduction.  As Scientific Director of ONE Fertility he has been an advocate of fertility preservation for patients facing a cancer diagnosis.  Mike sits on the advisory board for Fertile Future (fertilefuture.ca), a non-profit organization providing information and resources about fertility preservation for cancer patients.

 

This entry was posted in all, Medical Professionals, Oncofertility and tagged , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *